The AKR inhibitors sorbinil or zopolrestat blocked growth factor-induced binding activity of the transcription factor E2F1, phosphorylation of pRb, expression of cyclins and CDKs, generation of ROS, and activation of the PI3K/AKT pathway in colon cancer cells [121]. This evidence concerns the gene PCNA and malignant colon neoplasm.